Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

[Comment] Establishing cardiovascular safety of the small-molecule GLP-1 receptor agonist orforglipron in type 2 diabetes

Journal content Created on 16 Oct 2026 The Lancet

Published in

The Lancet, The Lancet (Reed Elsevier)

Content

There is no additional content. Please click on the source link to view more information.

Yu Mi Kang, Michael A Nauck

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 15
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement